Asian Pacific Journal of Cancer Prevention

  • 제15권6호
  • /
  • Pages.2815-2819
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Lack of any Impact of Histopathology Type on Prognosis in Patients with Early-Stage Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix

  • Teke, Fatma (Department of Radiation Oncology, Faculty of Medicine, Dicle University) ;
  • Yoney, Adnan (Department of Radiation Oncology, Faculty of Medicine, Karadeniz Technical University) ;
  • Teke, Memik (Department of Radiology, Faculty of Medicine, Dicle University) ;
  • Inal, Ali (Department of Medical Oncology, Faculty of Medicine, Dicle University) ;
  • Urakci, Zuhat (Department of Medical Oncology, Faculty of Medicine, Dicle University) ;
  • Eren, Bekir (Okmeydani Training and Research Hospital) ;
  • Zincircioglu, Seyit Burhanedtin (Department of Radiation Oncology, Faculty of Medicine, Dicle University) ;
  • Buyukpolat, Muhammed Yakup (Okmeydani Training and Research Hospital) ;
  • Ozer, Ali (Department of Obstetrics and Gynecology, Faculty of Medicine, Dicle University) ;
  • Isikdogan, Abdurrahman (Department of Medical Oncology, Faculty of Medicine, Dicle University) ;
  • Unsal, Mustafa (Okmeydani Training and Research Hospital)
  • 발행 : 2014.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: The aim of this study was to evaluate the prognosis of patients with stage IA-IIB cervical carcinoma and to investigate a possible correlation of histology with prognosis. Materials and Methods: Two hundred fifty one patients with adenocarcinoma and squamous cell carcinoma (SCC) histology for FIGO (International Federation of Gynecology and Obstetrics) stage IA-IIB uterine cervical carcinomas at the Radiation Oncology Clinic of GH Okmeydan Training and Research Hospital between January 1996 and December 2006 were selected, analyzed retrospectively and evaluated in terms of general characteristics and survival. Disease-free survival (DFS) and overall survival (OS) was calculated using the Kaplan-Meier method and differences were compared with the log-rank test. Multivariate analysis using a Cox-proportional hazards model was used to adjust for prognostic factors and to estimate hazard ratio (HR) with 95% confidence interval (CI). Results: There was no differences between the two tumour types in age, stage, pelvic nodal metastasis, parametrial invasion, surgical margin status, DSI, LVSI, maximal tumor diameter, grade, and treatment modalities. 5-year OS and DFS were 73% and 77%, versus 64% and 69%, for SCC and adenocarcinoma, respectively (p> 0.05). Multivariate analysis revealed independent prognostic factors including pelvic nodal metastasis and resection margin status for OS (p=0.008, p=0.002, respectively). Conclusions: Prognosis of FIGO stage IA-IIB cervical cancer patients was found to be the same for those with adenocarcinoma and SCC.

키워드

참고문헌

  1. Aoki Y, Sasaki M, Watanabe M, et al (2000). High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecologic Oncology, 77, 305-09. https://doi.org/10.1006/gyno.2000.5788
  2. Ayhan A1, Al RA, Baykal C, et al (2004). A comparison of prognoses of figo stage ib adenocarcinoma and squamous cell carcinoma. Int J Gynecol Cancer, 14, 279-85. https://doi.org/10.1111/j.1048-891X.2004.014211.x
  3. Baalbergen A, Veenstra Y, Stalpers L (2013). Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. Cochrane Database Syst Rev, 1, 6248.
  4. Chen YL, Ho CM, Chen CA, et al (2011). Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma. Int J Gynaecol Obstet, 112, 135-9. https://doi.org/10.1016/j.ijgo.2010.08.016
  5. Eifel PJ, Burke TW, Morris M, Smith TL (1995). Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol, 59, 38-44. https://doi.org/10.1006/gyno.1995.1265
  6. Eifel PJ, Morris M, Oswald MJ, Wharton JT, Delclos L (1990). Adenocarcinoma of the uterine cervix. prognosis and patterns of failure in 367 cases. Cancer, 65, 2507-14. https://doi.org/10.1002/1097-0142(19900601)65:11<2507::AID-CNCR2820651120>3.0.CO;2-9
  7. Fregnani JH, Soares FA, Novik PR, Lopes A, Latorre MR (2008). Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol, 136, 215-23. https://doi.org/10.1016/j.ejogrb.2006.10.021
  8. Gien LT, Beauchemin MC, Thomas G (2010). Adenocarcinoma: a unique cervical cancer. Gynecol Oncol, 116, 140-6. https://doi.org/10.1016/j.ygyno.2009.09.040
  9. Hopkins MP, Morley GW (1991). A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstetrics Gynecol, 77, 912-7.
  10. Huang YT, Wang CC, Tsai CS, et al (2012). Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy. Int J Radiat Oncol Biol Phys, 84, 420-7. https://doi.org/10.1016/j.ijrobp.2011.12.013
  11. Intaraphet S, Kasatpibal N, Siriaunkgul S, et al (2013). Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma. Asian Pac J Cancer Prev, 14, 5355-60. https://doi.org/10.7314/APJCP.2013.14.9.5355
  12. Irie T, Kigawa J, Minagawa Y, et al (2000). Prognosis and clinicopathological characteristics of ib-iib adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Eur J Surg Oncol, 26, 464-7. https://doi.org/10.1053/ejso.1999.0923
  13. Kasamatsu T, Onda T, Sawada M, Kato T, Ikeda S (2009). Radical hysterectomy for figo stage iib cervical cancer: clinicopathological characteristics and prognostic evaluation. Gynecol Oncol, 114, 69-74. https://doi.org/10.1016/j.ygyno.2009.03.026
  14. Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S (2012). Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. Gynecol Oncol, 125, 292-6. https://doi.org/10.1016/j.ygyno.2012.01.034
  15. Kleine W, Rau K, Schwoeorer D, Pfleiderer A (1989). Prognosis of the adenocarcinoma of the cervix uteri: a comparative study. Gynecol Oncol, 35, 145-9. https://doi.org/10.1016/0090-8258(89)90032-2
  16. Landoni F, Maneo A, Colombo A, et al (1997). Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet, 350, 535-40. https://doi.org/10.1016/S0140-6736(97)02250-2
  17. Lee KB, Lee JM, Park CY, et al (2006). What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? a matched case-control study. Int J Gynecol Cancer, 16, 1569-73. https://doi.org/10.1111/j.1525-1438.2006.00628.x
  18. Lee YY, Choi CH, Kim TJ, et al (2011). A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA. Gynecol Oncol, 120, 439-43. https://doi.org/10.1016/j.ygyno.2010.11.022
  19. Liu S, Semenciw R, Mao Y (2001). Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ, 164, 1151-2.
  20. Look KY, Brunetto VL, Clarke-Pearson DL, et al (1996). An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol, 63, 304-11. https://doi.org/10.1006/gyno.1996.0327
  21. Monk BJ, Tewari KS, Koh WJ (2007). Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol, 25, 2952-65. https://doi.org/10.1200/JCO.2007.10.8324
  22. Nakanishi T, Ishikawa H, Suzuki Y, et al (2000). A comparison of prognoses of pathologic stage IB adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol, 79, 289-93. https://doi.org/10.1006/gyno.2000.5935
  23. Peters RK, Chao A, Mack TM, et al (1986). Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst, 76, 423-8.
  24. Sherman ME, Wang SS, Carreon J, Devesa SS (2005). Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer, 103, 1258-64. https://doi.org/10.1002/cncr.20877
  25. Shingleton HM, Bell MC, Fremgen A, et al (1995). Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer, 76, 1948-55. https://doi.org/10.1002/1097-0142(19951115)76:10+<1948::AID-CNCR2820761311>3.0.CO;2-T
  26. Smith HO, Tiffany MF, Qualls CR and Key CR. (2000). The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-A 24-year population-based study. Gynecol Oncol, 78, 97-105. https://doi.org/10.1006/gyno.2000.5826
  27. Trattner M, Graf AH, Lax S, et al (2001). Prognostic factors in surgically treated stage Ib-IIb cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol, 82, 11-6. https://doi.org/10.1006/gyno.2001.6252
  28. Visioli CB, Zappa M, Ciatto S, Iossa A, Crocetti E (2004). Increasing trends of cervical adenocarcinoma incidence in central Italy despite extensive screening programme, 1985- 2000. Cancer Detect Prev, 28, 461-4. https://doi.org/10.1016/j.cdp.2004.07.007
  29. Vizcaino AP, Moreno V, Bosch FX, et al (1998). International trends in the incidence of cervical cancer: I. adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer, 75, 536-45. https://doi.org/10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U
  30. Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S (2004). Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer, 100, 1035-44. https://doi.org/10.1002/cncr.20064
  31. Xie XZ, Song K, Cui B, et al (2012). Clinical and pathological factors related to the prognosis of Chinese patients with stage Ib to IIb cervical cancer. Asian Pac J Cancer Prev, 13, 5505-10. https://doi.org/10.7314/APJCP.2012.13.11.5505

피인용 문헌

  1. Five-year survival and associated factors in women treated for cervical cancer at a reference hospital in the Brazilian Amazon vol.12, pp.11, 2017, https://doi.org/10.1371/journal.pone.0187579
  2. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis vol.143, pp.1, 2017, https://doi.org/10.1007/s00432-016-2246-9
  3. Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors vol.2017, pp.2314-6141, 2017, https://doi.org/10.1155/2017/2917925
  4. Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates vol.18, pp.1, 2018, https://doi.org/10.1186/s12885-018-5007-0
  5. Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer pp.1473-4877, 2019, https://doi.org/10.1080/03007995.2018.1502166